Sagimet Biosciences cleared an IND for TVB-3567, a FASN inhibitor for acne, with Phase 1 trials planned for 2025. Sagimet Biosciences Inc. announced the clearance of its Investigational New Drug (IND) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results